Back to top

Strength Seen in Adaptimmune Therapeutics (ADAP): Stock Soars 15.2%
August 29, 2017

Read MoreHide Full Article

Adaptimmune Therapeutics plc (ADAP - Free Report)   was a big mover last session, as the company saw its shares rise over 15% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $4.93 to $5.52 in the past one-month time frame.

The company has seen one positive estimate revisions in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved higher over the past few weeks, suggesting that more solid trading could be ahead for Adaptimmune Therapeutics. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

Adaptimmune Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%. 

A better-ranked stock in the Medical - Biomedical and Genetics industry is Regeneron Pharmaceuticals, Inc. (REGN - Free Report) , which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is ADAP going up? Or down? Predict to see what others think: Up or Down

Zacks' 10-Minute Stock-Picking Secret

Since 1988, the Zacks system has more than doubled the S&P 500 with an average gain of +25% per year. With compounding, rebalancing, and exclusive of fees, it can turn thousands into millions of dollars.

But here's something even more remarkable: You can master this proven system without going to a single class or seminar. And then you can apply it to your portfolio in as little as 10 minutes a month.

Learn the secret >>




In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Regeneron Pharmaceuticals, Inc. (REGN) - free report >>

Adaptimmune Therapeutics PLC (ADAP) - free report >>


More from Zacks Tale of the Tape

You May Like